APUS
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | 14.69 | $3M | $366,386 |
| 2026 Q2 | -11.77 | $0 | -$6M |
| 2026 Q1 | -22.60 | $0 | -$2M |
| 2025 Q4 | -0.92 | $0 | -$4M |
| 2025 Q3 | -14.00 | $0 | -$2M |
| 2025 Q2 | -26.00 | $0 | -$3M |
| 2025 Q1 |
| -3.48 |
| $0 |
| -$20,313 |
| 2024 Q4 | -2.70 | $0 | -$99,616 |